Citius Pharmaceuticals, Inc

Halal Rating :
To Be Determined
See Details
Last Price $0.63 Last updated:
Market Cap $121.34m
7D Change 2.29%
1 Year Change 2.29%

Company Overview

  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing
Exchange NASDAQ
Next Earnings Date Dec. 21, 2023

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $2.39m $15.26m $182205.0 - 7.63% 0.00%

Company Impact

Help us evaluate Citius Pharmaceuticals, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates